HANOI (Vietnam News/Asia News Network): A private hospital system in Vietnam said on Thursday (March 10) they are set to soon use AstraZeneca's Evusheld, a long-acting antibody combination (tixagevimab co-packaged with cilgavimab), for the prevention of Covid-19 for the most at-risk groups of the population.
According to the Ministry of Health, Vietnam logged 9,580 new cases of COVID-19, of which 6 were imported and quarantined upon arrival in the past 24 hours to 7pm on August 15.